Dalton Investments, Inc. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.

Quarter-by-quarter ownership
Dalton Investments, Inc. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q4 2019$1,810,000
-50.7%
15,551
-51.5%
1.14%
-50.7%
Q3 2019$3,669,000
-59.0%
32,051
-65.8%
2.32%
-42.9%
Q2 2019$8,944,000
-13.9%
93,851
-17.6%
4.06%
-10.5%
Q1 2019$10,389,000
+81.6%
113,851
+51.1%
4.54%
+47.4%
Q4 2018$5,720,000
+31.1%
75,351
+38.1%
3.08%
+50.6%
Q3 2018$4,364,00054,5512.04%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 149,457$11,773,0006.29%
INDUS CAPITAL PARTNERS, LLC 330,339$26,021,0002.54%
Perpetual Ltd 129,799$10,215,0001.32%
Black Creek Investment Management Inc. 396,525$31,234,0001.18%
RUDMAN ERROL M 28,701$2,261,0001.10%
COMGEST GLOBAL INVESTORS S.A.S. 635,752$50,078,0001.09%
Antipodean Advisors LLC 15,000$1,182,0000.96%
Hillhouse Capital Management 618,391$48,711,0000.83%
JUPITER ASSET MANAGEMENT LTD 215,866$17,004,0000.49%
Temasek Holdings (Private) Ltd 990,000$77,982,0000.48%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders